AUA 2020 Bladder Cancer

Viewing 1-20 of 26 articles

AUA 2020: Identifying the Frequency of Actionable Genomic Alterations in Localized and Metastatic Upper Tract Urothelial Carcinoma

AUA 2020: Inherited Cancer Predisposition Gene Variants in Patients with Non-Muscle Invasive Bladder Cancer

AUA 2020: Cost-Effectiveness of Maintenance BCG for Intermediate and High Risk Non-Muscle Invasive Bladder Cancer

AUA 2020: Expanding Kidney-Sparing Options for Patients with Low-Grade Upper Tract Urothelial Cancer

AUA 2020: A Phase III Study to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec for Patients with High-Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer: Papillary Disease Cohort Results

AUA 2020: Patient Matched Genomic Analysis of High-Grade Non-Muscle Invasive Bladder Cancer Specimens Pre- and Post-BCG Immunotherapy

AUA 2020: Pain Management in Urologic Surgery

AUA 2020: Phase 3 Results Of Vicinium In BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

AUA 2020: Predictors of Postoperative Complications after Robotic And Open Radical Cystectomy: An Analysis From The RAZOR Trial

AUA 2020: State-of-the-Art Lecture: Probiotics and Microbiota in Urology – Beginning of the End or End of the Beginning?

AUA 2020: Association of Pathologic Response to Neoadjuvant Pembrolizumab with Tumor Subtype from the PURE-01 Study

AUA 2020: Planned Secondary Analysis of PURE-01: Role of FDG-PET/CT in Evaluating Lymph Node Involvement of Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Pembrolizumab and Radical Cystectomy

AUA 2020: Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery (ERAS) Protocols: A Systematic Review and Individual Patient Data Meta-Analysis

AUA 2020: Gender Based Variations in the Detection of Bladder Cancer with Blue Light Cystoscopy: Insights from a Multicenter Registry

AUA 2020: Role of Blue Light Cystoscopy in Detecting Invasive Bladder Tumor: Data from Multi-Institutional Registry

AUA 2020: Multi-Institutional Outcomes of Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Undergo Radical Cystectomy After BCG and Subsequent Salvage Intravesical Therapy

AUA 2020: Malignant Urinary Cytology of Unknown Origin: Blue Light Flexible Cystoscopy at the Outpatient Clinic May Be a Valuable Diagnostic Tool

AUA 2020: What to Do During BCG Shortage for High-Risk NMIBC Patients?

AUA 2020: Surgical Techniques: Tips & Tricks: Oncology: Bladder Cancer Blue Light Cystoscopy

AUA 2020: AUA Guidelines Case-Based Panel Discussion: Bladder Cancer (Non-Muscle and Muscle Invasive)

1
2